The estimated Net Worth of Patricia B Prichep is at least $2.54 Millón dollars as of 8 May 2024. Ms. Prichep owns over 8,000 units of Cel-Sci stock worth over $274,145 and over the last 21 years she sold CVM stock worth over $0. In addition, she makes $2,266,470 as Senior Vice President - Operations y Corporate Secretary at Cel-Sci.
Sign up
Ms. Prichep CVM stock SEC Form 4 insiders trading
Patricia has made over 7 trades of the Cel-Sci stock since 2003, according to the Form 4 filled with the SEC. Most recently she bought 8,000 units of CVM stock worth $11,120 on 8 May 2024.
The largest trade she's ever made was buying 25,303 units of Cel-Sci stock on 28 September 2006 worth over $14,676. On average, Patricia trades about 512 units every 58 days since 2003. As of 8 May 2024 she still owns at least 232,326 units of Cel-Sci stock.
You can see the complete history of Ms. Prichep stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Patricia Prichep biography
Patricia B. Prichep serves as Senior Vice President - Operations, Corporate Secretary of the Company. Ms. Prichep was CEL-SCI's Director of Operations. Ms. Prichep became CEL-SCI's Corporate Secretary in May 2000. She is responsible for all day-to-day operations of CEL-SCI, including human resources and is the liaison with CEL-SCI’s independent registered public accounting firm for financial reporting. From June 1990 to December 1992, Ms. Prichep was the Manager of Quality and Productivity for the NASD’s Management, Systems and Support Department and was responsible for the internal auditing and work flow analysis of operations. Between 1982 and 1990, Ms. Prichep was Vice President and Operations Manager for Source Capital, Ltd. She handled all operations and compliance for Source Capital and was licensed as a securities broker. Ms. Prichep received her B.A. from the University of Bridgeport in Connecticut.
What is the salary of Patricia Prichep?
As the Senior Vice President - Operations y Corporate Secretary of Cel-Sci, the total compensation of Patricia Prichep at Cel-Sci is $2,266,470. There are 1 executives at Cel-Sci getting paid more, with Geert Kersten having the highest compensation of $4,546,360.
How old is Patricia Prichep?
Patricia Prichep is 69, she's been the Senior Vice President - Operations y Corporate Secretary of Cel-Sci since 2000. There are 6 older and 7 younger executives at Cel-Sci. The oldest executive at Cel-Sci Corp. is Dr. Daniel H. Zimmerman Ph.D., 80, who is the Sr. VP of Research & Cellular Immunology.
What's Patricia Prichep's mailing address?
Patricia's mailing address filed with the SEC is 8229 BOONE BLVD., SUITE 802, , VIENNA, VA, 22182.
Insiders trading at Cel-Sci
Over the last 21 years, insiders at Cel-Sci have traded over $3,069,559 worth of Cel-Sci stock and bought 1,693,350 units worth $1,328,136 . The most active insiders traders include Clara Maximilian De, Geert R Kersten y Eyal Talor. On average, Cel-Sci executives and independent directors trade stock every 50 days with the average trade being worth of $42,938. The most recent stock trade was executed by Robert Eugene Watson on 8 May 2024, trading 20,000 units of CVM stock currently worth $27,800.
What does Cel-Sci do?
cel-sci corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. the company's lead investigational immunotherapy is multikine, which is under phase iii clinical trial for the treatment of head and neck cancer. its ligand epitope antigen presentation system (leaps), a pre-clinical patented t-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. the company also develops leaps-h1n1-dc; cel-2000 and cel-4000 are product candidates for the treatment of rheumatoid arthritis; and leaps cov-19, a product candidate to treat covid-19 coronavirus. cel-sci corporation has a collaboration agreement with the university of georgia's center for vaccines and immunology to develop leaps covid-19 immunotherapy. the company was founded in 1983 and is headquartered in vienna, virginia.
What does Cel-Sci's logo look like?
Complete history of Ms. Prichep stock trades at Cel-Sci
Cel-Sci executives and stock owners
Cel-Sci executives and other stock owners filed with the SEC include:
-
Geert Kersten,
Chief Executive Officer, Treasurer, Director -
Patricia Prichep,
Senior Vice President - Operations, Corporate Secretary -
Eyal Talor,
Chief Scientific Officer -
Daniel Zimmerman,
Senior Vice President - Research, Cellular Immunology -
John Cipriano,
Senior Vice President - Regulatory Affairs -
Peter Young,
Independent Director -
Robert Watson,
Independent Director -
Bruno Baillavoine,
Independent Director -
Geert R. Kersten,
CEO, Principal Accounting & Financial Officer, Treasurer and Director -
Geert R. Kersten Esq.,
Chief Exec. & Financial Officer, Treasurer and Director -
Dr. Eyal Talor Ph.D.,
Chief Scientific Officer -
Patricia B. Prichep,
Sr. VP of Operations & Corp. Sec. -
Dr. Daniel H. Zimmerman Ph.D.,
Sr. VP of Research & Cellular Immunology -
John Cipriano,
Sr. VP of Regulatory Affairs -
Clara Maximilian De,
President -
Alexander G Esterhazy,
Director -
C Richard Kinsolving,
Director -
Gail K Naughton,
Director